促红细胞生成素联合养血益肾方在
2017-03-20周珂董扬洲周红霞王小玲陈
周珂++董扬洲++周红霞++王小玲++陈毅君++付铁娇



【摘要】目的:观察养血益肾方对血液透析贫血患者的临床疗效。方法:将维持性血液透析贫血患者91例分为促红素组(E组)30例、养血益肾组(Y组)29例和强化组(E+Y组)32例,分别给予促红素、养血益肾方和促红素联合养血益肾方治疗8周,比较治疗前后各组的铁调素(Hepcidin)、血红蛋白(HGB)、铁蛋白(SF)。结果:E+Y组Hepcidin、HCT、HGB、SF等指标的改善优于E组和Y组(P<005),E组对Hepcidin和SF的改善优于Y组(P<005),而Y组对HCT和HGB的改善与E组无统计学差异(P>005)。结论:养血益肾方对血液透析贫血患者具有纠正贫血的作用,可能与其在一定程度上降低Hepcidin,提高SF有关,但更与直接提高HCT和HGB关系更密切。
【关键词】养血益肾;血液透析;贫血;疗效;Hepcidin
【中图分类号】R4595【文献标志码】 A【文章编号】1007-8517(2017)04-0124-03
Effect of Yangxue Yishen Decoction on Hepcidin and Ferroproteinin Hemodialysis Patients ZHOU Ke1DONG Yangzhou1ZHOU Hongxia1WANG Xiaoling1CHEN Yijun1FU Tiejiao2
1The Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine,Changsha 410005,China;
2 Hongshan Community Health Service Center in Changsha, Changsha 410000,ChinaAbstract:Objective To observe the clinical effect of Yangxue Yishen Decoction on hemodialysis patients with anemia Methods 91 cases of maintenance hemodialysis patients with anemia were randomly divided into erythropoietin group(E group)30 cases, Yangxue Yishen Decoction group(Y group)29 cases and intensive group(E+Y group)32 cases,which were given erythropoietin essence, Yangxue Yishen Decoction, Yangxue Yishen Decoction and erythropoietin for 8 weeks Iron regulated hormone(hepcidin), hemoglobin(Hgb) and ferritin(SF) each group were compared before and after being treated ResultsThe improvement of Hepcidin, HCT, HGB, SF of E+Y group were better than those of E group and Y group(P<005) The improvement of SF and Hepcidin in E group was better than Y group(P<005), while the improvement of HCT and HGB in Y group was better than E group(P<005) Conclusion Mechanism of Yangxue Yishen Decoction correcting anemia in patients with hemodialysis may be related to decreasing hepcidin and improving the SF some extent, but improving HCT and HGB directly more closely
Keywords:Yangxue Yishen Decoction;Hemodialysis;Anemia;Curative Effect; Hepcidin
有统计显示,约有70%~90%维持性血液透析患者存在不同程度的贫血[1]。王艳丽研究显示[2],CKD1~5期患者贫血率分别为1923%、3823%、4875%、826%、977%,其中透析组CKD患者的贫血率高达9723%,而且肾功能与贫血发生率有显著相关性。积极纠正贫血对于慢性肾衰患者有积极意义。长期以来,中药对于肾性贫血的作用屡有报道[3-4]。笔者观察了自拟之养血益肾方对血液透析贫血患者的疗效和相关指标的变化,现报告如下。
1资料与方法
1.1一般資料选取2015年5月至2016年5月在湖南中医药大学第二附属医院维持性血液透析患者91例,分为促红素组(E组)、养血益肾组(Y组)和强化组(E+Y组),其中E组患者30例,Y组患者29例,E+Y组患者32例。E组中男性19例,女性11例;年龄38~67岁,平均(4234±1725)岁;病程7~13个月,平均(83±36)个月;原发病:慢性肾小球肾炎16例,糖尿病肾病9例,高尿酸性肾病3例,紫癜性肾病2例;贫血程度:轻度贫血17例,中度贫血10例,重度贫血3例。……
